Recruiting Diabetic Retinopathy Studies in Ann Arbor
About Diabetic Retinopathy Clinical Trials in Ann Arbor
Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.
There are currently 1 diabetic retinopathy clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 180 participants. Research is being sponsored by University of Michigan. Clinical trial participation is free and participants receive study-related medical care at no cost.
Diabetic Retinopathy Clinical Trials in Ann Arbor — FAQ
Are there diabetic retinopathy clinical trials in Ann Arbor?
Yes, there are 1 diabetic retinopathy clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ann Arbor?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.
Are clinical trials in Ann Arbor free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.
What diabetic retinopathy treatments are being tested?
The 1 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.
Data updated August 29, 2026 from ClinicalTrials.gov